These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7603648)

  • 21. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.
    Grant KA; Colombo G
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1241-7. PubMed ID: 8450461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lead-induced changes in NMDA receptor complex binding: correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration.
    Cory-Slechta DA; Garcia-Osuna M; Greenamyre JT
    Behav Brain Res; 1997 May; 85(2):161-74. PubMed ID: 9105573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
    Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MK-801 administration during ethanol withdrawal in neonatal rat pups attenuates ethanol-induced behavioral deficits.
    Thomas JD; Weinert SP; Sharif S; Riley EP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1218-25. PubMed ID: 9347082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (+)-N-Allylnormetazocine (NANM)-like discriminative stimulus effects of N-methyl-D-aspartate (NMDA) antagonists.
    Willetts J; Rice A; Balster RL
    Behav Pharmacol; 1990; 1(5):453-458. PubMed ID: 11175430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.
    Cory-Slechta DA; Pokora MJ; Fox RA; O'Mara DJ
    Neurotoxicology; 1996; 17(2):445-57. PubMed ID: 8856740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatally malnourished female but not male rats show increased sensitivity to MK-801 in a differential reinforcement of low rates task.
    Tonkiss J; Almeida SS; Galler JR
    Behav Pharmacol; 1998 Feb; 9(1):49-60. PubMed ID: 9832948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
    Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesic responses in the rat.
    Cox J; Westbrook RF
    Q J Exp Psychol B; 1994 May; 47(2):187-210. PubMed ID: 8052728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
    Stuchlík A; Vales K
    Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo effects of lead on specific 3H-MK-801 binding to NMDA-receptors in the brain of mice.
    Schulte S; Müller WE; Friedberg KD
    Neurotoxicology; 1995; 16(2):309-17. PubMed ID: 7566690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
    Kalivas PW; Alesdatter JE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):486-95. PubMed ID: 8229779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?
    Jackson A; Sanger DJ
    Psychopharmacology (Berl); 1988; 96(1):87-92. PubMed ID: 2906445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats.
    Scalzo FM; Burge LJ
    Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats.
    Balster RL; Nicholson KL; Sanger DJ
    Drug Alcohol Depend; 1994 Jun; 35(3):211-6. PubMed ID: 7956750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discriminative stimulus effects of phencyclidine: pharmacologically specific interactions with delta 9- and delta 8-tetrahydrocannabinol.
    Doty P; Dykstra LA; Picker MJ
    Drug Alcohol Depend; 1994 Apr; 35(2):151-8. PubMed ID: 8055736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of adult rats to lead-induced changes in NMDA receptor complex function.
    Cory-Slechta DA; Flaugher CL; Evans SB; Pokora MJ; Greenamyre JT
    Neurotoxicol Teratol; 1997; 19(6):517-30. PubMed ID: 9392787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists.
    Sanger DJ; Zivkovic B
    J Psychopharmacol; 1989 Jan; 3(4):198-204. PubMed ID: 22282909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.